ES2193722T3 - Desformoterol y procedimiento para su preparacion. - Google Patents
Desformoterol y procedimiento para su preparacion.Info
- Publication number
- ES2193722T3 ES2193722T3 ES99930556T ES99930556T ES2193722T3 ES 2193722 T3 ES2193722 T3 ES 2193722T3 ES 99930556 T ES99930556 T ES 99930556T ES 99930556 T ES99930556 T ES 99930556T ES 2193722 T3 ES2193722 T3 ES 2193722T3
- Authority
- ES
- Spain
- Prior art keywords
- amino
- preparation
- desformoterol
- procedure
- benzenemethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/103,212 US5965622A (en) | 1998-06-23 | 1998-06-23 | Desformoterol and process for its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2193722T3 true ES2193722T3 (es) | 2003-11-01 |
Family
ID=22293976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99930556T Expired - Lifetime ES2193722T3 (es) | 1998-06-23 | 1999-06-22 | Desformoterol y procedimiento para su preparacion. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5965622A (https=) |
| EP (1) | EP1093450B1 (https=) |
| JP (1) | JP4328021B2 (https=) |
| AT (1) | ATE238271T1 (https=) |
| AU (1) | AU747329B2 (https=) |
| CA (1) | CA2335154C (https=) |
| DE (1) | DE69907190T2 (https=) |
| ES (1) | ES2193722T3 (https=) |
| WO (1) | WO1999067198A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20010428A1 (it) * | 2001-03-02 | 2002-09-02 | Chemo Breath S A | Composizioni ad uso inalatorio a base di formoterolo |
| US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| US20040023935A1 (en) * | 2002-08-02 | 2004-02-05 | Dey, L.P. | Inhalation compositions, methods of use thereof, and process for preparation of same |
| US20050158248A1 (en) * | 2002-08-21 | 2005-07-21 | Xian-Ming Zeng | Method of preparing dry powder inhalation compositions |
| AU2003269989B8 (en) * | 2002-08-21 | 2009-11-12 | Norton Healthcare Ltd. | Inhalation composition |
| GB0219511D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
| US20040109826A1 (en) * | 2002-12-06 | 2004-06-10 | Dey, L.P. | Stabilized albuterol compositions and method of preparation thereof |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| WO2008035380A2 (en) * | 2006-09-19 | 2008-03-27 | Natco Pharma Limited | An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts |
| CN101391962A (zh) * | 2007-09-21 | 2009-03-25 | 北京德众万全药物技术开发有限公司 | 一种高纯度的(R)-α-(溴甲基)-4-苄氧基-3-硝基苯甲醇及其制备方法 |
| CN101462971B (zh) * | 2007-12-19 | 2014-05-07 | 北京德众万全药物技术开发有限公司 | 高纯度的用于制备福莫特罗的关键中间体及其制备方法 |
| ES2539947T3 (es) | 2008-06-02 | 2015-07-07 | Cipla Limited | Procedimiento para la síntesis de arformoterol |
| WO2010128355A2 (en) | 2008-12-26 | 2010-11-11 | Actavis Group Ptc Ehf | Improved processes for preparing substantially pure arformoterol and its intermediates |
| US8282512B1 (en) | 2009-03-26 | 2012-10-09 | Warrior Sports, Inc. | Lacrosse head |
| CN101921200B (zh) * | 2009-06-16 | 2014-01-15 | 上海医药工业研究院 | 一种n-苄基-1-(4-甲氧基苯基)-2-丙胺的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2031407A6 (es) * | 1988-10-05 | 1992-12-01 | Lasa Lab | Mejoras introducidas en el objeto de la patente principal n{ 8703715 por: procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2-((2-(4-metoxifenil)-1-metiletil)amino)etil)fenil)formamida". |
-
1998
- 1998-06-23 US US09/103,212 patent/US5965622A/en not_active Expired - Lifetime
-
1999
- 1999-05-05 US US09/305,534 patent/US6071971A/en not_active Expired - Lifetime
- 1999-06-22 CA CA002335154A patent/CA2335154C/en not_active Expired - Lifetime
- 1999-06-22 EP EP99930556A patent/EP1093450B1/en not_active Expired - Lifetime
- 1999-06-22 AT AT99930556T patent/ATE238271T1/de not_active IP Right Cessation
- 1999-06-22 AU AU47072/99A patent/AU747329B2/en not_active Expired
- 1999-06-22 DE DE69907190T patent/DE69907190T2/de not_active Expired - Lifetime
- 1999-06-22 WO PCT/US1999/014082 patent/WO1999067198A1/en not_active Ceased
- 1999-06-22 JP JP2000555854A patent/JP4328021B2/ja not_active Expired - Lifetime
- 1999-06-22 ES ES99930556T patent/ES2193722T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5965622A (en) | 1999-10-12 |
| ATE238271T1 (de) | 2003-05-15 |
| CA2335154C (en) | 2008-11-18 |
| JP2002518468A (ja) | 2002-06-25 |
| AU4707299A (en) | 2000-01-10 |
| DE69907190T2 (de) | 2004-02-12 |
| EP1093450B1 (en) | 2003-04-23 |
| JP4328021B2 (ja) | 2009-09-09 |
| US6071971A (en) | 2000-06-06 |
| EP1093450A1 (en) | 2001-04-25 |
| CA2335154A1 (en) | 1999-12-29 |
| DE69907190D1 (de) | 2003-05-28 |
| AU747329B2 (en) | 2002-05-16 |
| WO1999067198A1 (en) | 1999-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2193722T3 (es) | Desformoterol y procedimiento para su preparacion. | |
| ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
| DOP2002000429A (es) | Imidazotriazinas | |
| CO5180579A1 (es) | Composicion oral solida que comprende levidopa, carbidopa y entacapone | |
| NO20051986L (no) | Sammenhengende frigivelsesavlevering av amfetaminsalter. | |
| AR035158A1 (es) | Inhibidores de recaptacion de norepinefrina altamente selectivos y metodo para usar los mismos | |
| UA81629C2 (ru) | Применение композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней | |
| ATE381535T1 (de) | Phenethanolaminderivate | |
| AR030068A1 (es) | Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| BR0209957A (pt) | Composto, processo para a preparação de um composto, composição farmacêutica que compreende um composto, utilização desse composto e processo para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade | |
| DE60320007D1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| BRPI0409624A (pt) | 2-hidróxi-3-diaminoalcanos de benzamida | |
| BR0213540A (pt) | Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos | |
| BR0207883A (pt) | Composições de medicamentos à base de anticolenérgicos e inibidores de pde-iv | |
| BRPI0509655A (pt) | uso de derivados de 9h-purina-2,6-diamina no tratamento de doenças proliferativas e novos derivados de 9h-purina-2,6-diamina | |
| AR013079A1 (es) | Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios | |
| BR0314314A (pt) | Derivados do éter 4-pirrolidina-fenil-benzìlico | |
| BRPI0408863A (pt) | composto, composição farmacêutica, método para tratar doenças, e, uso de um composto. | |
| BR0209845A (pt) | Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas | |
| AR047719A1 (es) | Procedimiento para el tratamiento de trastornos de depresion y ansiedad mediante terapia de combinacion que comprenden un ligando alfa-2-delta y un ssri y/o un snri | |
| AR003473A1 (es) | Uso de la l-carnitina o una acil l-carnitina en donde el acilo es seleccionado del grupo que comprende acetilo, propionilo, butirilo, valerilo e isovalerilo, o de una sal farmacologicamente aceptable de las mismas para la produccion de un medicamento | |
| BRPI0415781A (pt) | método para o tratamento de diabetes em um paciente e kit farmacêutico | |
| AR023687A1 (es) | Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa | |
| BRPI0211635B8 (pt) | composto ciclo-hexil-sulfona, uso do mesmo, e, composição farmacêutica |